Science and Medicine Group

IBO (v.34, iss.19) — Annual 2026 Forecast 15 Jan 2026

Report details
33 Figures
34 Tables

The IBO 2026 Market Forecast
- 2025
- 2026
- Economic and Political Overview
End-Market Forecast: Strengthening Pharma Demand Overpowers Weak Academic Market…
Regional Forecast: India Shines Brightest, China Makes Positive Strides
Life Science Instrumentation: Signs of Resilience Through the Storm
GLP-1s Provide Weighty Opportunity for MS, but Market Weakness Hampers Progress
Lab Automation Returns to Modest Growth After a Bumpy 2025
Sweating the Small Stuff: Nano Analysis Microscope Demand Shows Uncertainty in…
Chromatography Eyes a Gallop into 2026: China May Spur Basic R&D Recovery
Market Reset: How Tariffs, Public Funding Cuts and Healthcare Innovation Shaped…
Atomic Spectroscopy: Gradual Improvement in Industrial Markets, Pharma Stays…
Sample Preparation Returns to Growth Led by Applied and Pharma End-markets
Regional Energy Markets Power 2026 Materials Characterization
From Discovery to Deliverables: How 2025 Shifted Lab Spend Toward Bioproduction…
2025 Trends and Developments
- Tariffs Cause Disruption
- US Government Targets Academia
- US Government Upheaval
- AI’s Momentum Reaches a New Level
- Life Sciences Face Headwinds
Executive Briefing
- Danaher Announces Preliminary Results
- Illumina Reveals 2025 Revenue Estimates
- Revvity Announces Preliminary Results and Workforce Reduction
- Bruker Discloses Preliminary Full-Year 2025 Results
- Tecan Confirms 2025 Guidance
- 10x Announces Preliminary 2025 Results and CLIA Lab
- PacBio Expects Full-Year 2025 Growth of 4%
- Oxford Nanopore Estimates 2025 Growth Slightly Ahead of Forecast
- Cytek Announces 2025 Growth
- Standard BioTools Announces Preliminary Results
- Twist Estimates Fiscal First Quarter Results
- SOPHiA GENETICS Announces 2026 Forecast and New CEO
- MaxCyte Reports Preliminary Results
- Markes International Sold
- Bruker Acquires Remainder of TOFWERK
- Quanterix Names New CEO
- Life Science QMS and LIMS Firm Acquired
News
- Broad-Based Companies
  - Company Announcements
- Sequencing
  - Company Announcements
  - Product Introductions
- Life Science Instruments
  - Company Announcements
  - Gene-Based Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
  - Cell-Based Analysis
  - Company Announcements
  - Product Introductions
  - Protein-Based Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Surface Science
  - Company Announcements
  - Product Introductions
Bottom Line

IBO (v.34, iss.19) — Annual 2026 Forecast

15 Jan 2026

Request Access

Table of Contents

The IBO 2026 Market Forecast
- 2025
- 2026
- Economic and Political Overview
End-Market Forecast: Strengthening Pharma Demand Overpowers Weak Academic Market
Regional Forecast: India Shines Brightest, China Makes Positive Strides
Life Science Instrumentation: Signs of Resilience Through the Storm
GLP-1s Provide Weighty Opportunity for MS, but Market Weakness Hampers Progress
Lab Automation Returns to Modest Growth After a Bumpy 2025
Sweating the Small Stuff: Nano Analysis Microscope Demand Shows Uncertainty in a Muddled Market
Chromatography Eyes a Gallop into 2026: China May Spur Basic R&D Recovery
Market Reset: How Tariffs, Public Funding Cuts and Healthcare Innovation Shaped Molecular Spectroscopy in 2025
Atomic Spectroscopy: Gradual Improvement in Industrial Markets, Pharma Stays Strong
Sample Preparation Returns to Growth Led by Applied and Pharma End-markets
Regional Energy Markets Power 2026 Materials Characterization
From Discovery to Deliverables: How 2025 Shifted Lab Spend Toward Bioproduction and Pharma
2025 Trends and Developments
- Tariffs Cause Disruption
- US Government Targets Academia
- US Government Upheaval
- AI’s Momentum Reaches a New Level
- Life Sciences Face Headwinds
Executive Briefing
- Danaher Announces Preliminary Results
- Illumina Reveals 2025 Revenue Estimates
- Revvity Announces Preliminary Results and Workforce Reduction
- Bruker Discloses Preliminary Full-Year 2025 Results
- Tecan Confirms 2025 Guidance
- 10x Announces Preliminary 2025 Results and CLIA Lab
- PacBio Expects Full-Year 2025 Growth of 4%
- Oxford Nanopore Estimates 2025 Growth Slightly Ahead of Forecast
- Cytek Announces 2025 Growth
- Standard BioTools Announces Preliminary Results
- Twist Estimates Fiscal First Quarter Results
- SOPHiA GENETICS Announces 2026 Forecast and New CEO
- MaxCyte Reports Preliminary Results
- Markes International Sold
- Bruker Acquires Remainder of TOFWERK
- Quanterix Names New CEO
- Life Science QMS and LIMS Firm Acquired
News
- Broad-Based Companies
  - Company Announcements
- Sequencing
  - Company Announcements
  - Product Introductions
- Life Science Instruments
  - Company Announcements
  - Gene-Based Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
  - Cell-Based Analysis
  - Company Announcements
  - Product Introductions
  - Protein-Based Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Surface Science
  - Company Announcements
  - Product Introductions
Bottom Line